These posts were published on ZYX Short Sell Change Alert.
The short zone for Acorda Therapeutics (ACOR) is $24.50 to $26.40. Since the stock is moving fast we want to get this to you quickly. We will do another post shortly with more details. Maximum position size is 30% of full core position size.
We have a long history with Acorda Therapeutics (ACOR) from years ago when ACOR started talking about its drug Ampyra, long before the approval of the drug. We have repeatedly been proven right and in the process have made a lot of money.
The next catalyst for marijuana investors may come from an obvious place: Big Tobacco.
While alcoholic-beverage companies have been active in the marijuana industry, Big Tobacco curiously has not.
But new comments made by an Altria MO executive show that the company is evaluating opportunities in marijuana. Altria owns Phillip Morris USA, which makes Marlboro cigarettes. Before digging deeper into the logic of cigarette companies getting into marijuana, let’s review marijuana stocks with the help of a chart.
Please click here for an annotated chart of marijuana stock Canopy Growth CGC. Please note the following:
• The chart shows the sell signal given by The Arora Report in June right at the prior peak.… Please click here or the title below to read more.